R&D and Pharmaceutical Collaboration

Research & Therapeutic Platforms: Partnering to Solve Critical Health Challenges

Pharmaceutical, Biotechnology, Academic Research

Our Pitch: For our partners in the pharmaceutical and biotech space, we function as a dedicated extension of your R&D team. Our chitosan platform offers a promising pathway for solving complex drug delivery challenges. We engage in collaborative, milestone-based projects to assess feasibility and develop novel delivery systems for high-value active pharmaceutical ingredients (APIs).

Our R&D Focus Areas Include:

• Oncology (Anti-Cancer Delivery):
  • Our technology is an ideal platform for enhancing the delivery of chemotherapeutic agents. We work with partners to explore strategies for improving drug solubility, reducing systemic toxicity, and investigating pathways for targeted delivery to tumor sites.
• Protein & Peptide Delivery (e.g., Antivirals):
  • We specialize in encapsulating and protecting large, sensitive molecules like proteins and peptides from enzymatic degradation. This opens doors for novel oral or targeted delivery routes for molecules that have traditionally required injection.
• Gene Therapy & Nucleic Acid Delivery:
  • The cationic nature of chitosan makes it a compelling non-viral vector for the delivery of genetic material like siRNA and pDNA. We partner with research organizations to develop next-generation gene delivery vehicles.

Our Partnership Model: We structure our pharmaceutical collaborations through feasibility studies, joint development agreements, and technology licensing. Our process is designed to align with your pre-clinical and clinical development pathways.